SynthesisPloS one2024

Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis.

Lingyan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.